Literature DB >> 9276644

Induction of the apoptosis-promoting protein Bak by perillyl alcohol in pancreatic ductal adenocarcinoma relative to untransformed ductal epithelial cells.

K R Stayrook1, J H McKinzie, Y D Burke, Y A Burke, P L Crowell.   

Abstract

Perillyl alcohol has antitumor activity toward pancreas and other cancers with low toxicity. Here, we have investigated the mechanism of action responsible for the differential sensitivity of malignant versus non-malignant pancreatic cells to the drug. We report that the rate of apoptosis is over 6-fold higher in perillyl alcohol-treated pancreatic adenocarcinoma cells than in untreated cells, and that the effect of perillyl alcohol on pancreatic tumor cells is significantly greater than its effect on non-malignant pancreatic ductal cells. Moreover, the perillyl alcohol-induced increase in apoptosis in all of the pancreatic tumor cells is associated with a 2- to 8-fold increase in the expression of the proapoptotic protein Bak, but Bak expression is not affected by perillyl alcohol in non-malignant cells. Thus, the antitumor activity of perillyl alcohol toward pancreatic cancers may be due to preferential stimulation of Bak-induced apoptosis in malignant versus normal cells. Bak may, therefore, be a useful biomarker for the chemopreventive and therapeutic effects of perillyl alcohol.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9276644     DOI: 10.1093/carcin/18.8.1655

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  14 in total

Review 1.  Chemoprevention for pancreatic cancer.

Authors:  Robert A Wolff
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 2.  Chemoprevention strategies for pancreatic cancer.

Authors:  Silvia D Stan; Shivendra V Singh; Randall E Brand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-05-04       Impact factor: 46.802

3.  Farnesol activates the intrinsic pathway of apoptosis and the ATF4-ATF3-CHOP cascade of ER stress in human T lymphoblastic leukemia Molt4 cells.

Authors:  Joung Hyuck Joo; Eiichiro Ueda; Carl D Bortner; Xiao-Ping Yang; Grace Liao; Anton M Jetten
Journal:  Biochem Pharmacol       Date:  2015-08-11       Impact factor: 5.858

Review 4.  Farnesyltransferase inhibitors: potential role in the treatment of cancer.

Authors:  A D Cox
Journal:  Drugs       Date:  2001       Impact factor: 9.546

5.  Repurposing L-Menthol for Systems Medicine and Cancer Therapeutics? L-Menthol Induces Apoptosis through Caspase 10 and by Suppressing HSP90.

Authors:  Uzma Faridi; Sunita S Dhawan; Shaifali Pal; Sanchita Gupta; Ashutosh K Shukla; Mahendra P Darokar; Ashok Sharma; Ajit K Shasany
Journal:  OMICS       Date:  2016-01

Review 6.  Molecular mechanisms involved in farnesol-induced apoptosis.

Authors:  Joung Hyuck Joo; Anton M Jetten
Journal:  Cancer Lett       Date:  2009-06-10       Impact factor: 8.679

7.  Perillyl alcohol for pediatric TP53- and RAS-mutated SHH-medulloblastoma: an in vitro and in vivo translational pre-clinical study.

Authors:  Marcela de Oliveira Silva; Graziella Ribeiro de Sousa; Sarah Capelupe Simões; Patrícia Nicolucci; Edwin Tamashiro; Fabiano Saggioro; Ricardo Santos de Oliveira; María Sol Brassesco
Journal:  Childs Nerv Syst       Date:  2021-04-22       Impact factor: 1.475

8.  Perillyl Alcohol Inhibits Breast Cell Migration without Affecting Cell Adhesion.

Authors:  Johanna E. Wagner; Janice L. Huff; William L. Rust; Karl Kingsley; George E. Plopper
Journal:  J Biomed Biotechnol       Date:  2002

Review 9.  Antitumor activity of monoterpenes found in essential oils.

Authors:  Marianna Vieira Sobral; Aline Lira Xavier; Tamires Cardoso Lima; Damião Pergentino de Sousa
Journal:  ScientificWorldJournal       Date:  2014-10-14

10.  Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells.

Authors:  Chunwan Lu; Dafeng Yang; Maria E Sabbatini; Aaron H Colby; Mark W Grinstaff; Nicholas H Oberlies; Cedric Pearce; Kebin Liu
Journal:  BMC Cancer       Date:  2018-02-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.